Glycolysis-inhibiting tumor cell-derived microparticles to enhance immunogenic cell death for synergistic cancer immunotherapy
Miya Zhang(National University of Singapore), Ming Ma(National University of Singapore), Pui Lai Rachel Ee(National University of Singapore), Huize Han(National University of Singapore), Guocan Yu(Tsinghua University), Zhijuan Yang(Ningxia Medical University), Jian Xu(University of California, Los Angeles), Wei Tang
Cited by 4
Related Papers
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
The effects of polymeric nanostructure shape on drug delivery
|Advanced Drug Delivery Reviews|2011|507
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Mixed micelles self-assembled from block copolymers for drug delivery
|Current Opinion in Colloid & Interface Science|2010|311